A Phase IIb Randomised Controlled Trial of Continuous Beta-Lactam Infusion Compared With Intermittent Beta-Lactam Dosing in Critically Ill Patients With Severe Sepsis (2012–2017)
- Grant type:
- Baxter Healthcare Pty Ltd
- Researchers:
-
-
- Funded by:
- Baxter Healthcare Pty Ltd
